menu
    • menu

    Company profile for Suven Pharmaceuticals

    NEW Drugs in Dev: 1
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Suven has established its core competency in cyanation and heterocyclic chemistry, including pyrimidines, quinolones, thiazoles, and imidazoles, in addition to demonstrating our proficiency in Carbohydrate and Chiral chemistry including tetrahydrofurans, amino acids and sulfoxides and dabbled into each and every chemistry except fluorination and phosgenation from gram to multi-ton scale.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Suven Pharmaceuticalsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    202, A-Wing, Galaxy Towers, Plot No-1, Hyderabad Knowledge City, TSIIC, Raidur...
    Telephone
    Telephone
    +91 4023549414
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.suvenpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    China's India Headache: The Growing Pharmaceutical Industry
    China's India Headache: The Growing Pharmaceutical Industry

    25 May 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/chinas-india-headache-the-growing-pharmaceutical-industry/articleshow/121384015.cms

    ECONOMICTIMES
    25 May 2025
    Share Share
    Suven Pharmaceuticals is now Cohance Lifesciences
    Suven Pharmaceuticals is now Cohance Lifesciences

    08 May 2025

    // PRESS RELEASE

    https://www.cohance.com/wp-content/uploads/2025/06/Cohance_SE_intimation_name_change_7May2025.pdf

    PRESS RELEASE
    08 May 2025
    Share Share
    Effective date for Scheme of Amalgamation
    Effective date for Scheme of Amalgamation

    25 Apr 2025

    // PRESS RELEASE

    https://www.cohance.com/wp-content/uploads/2025/06/SuvenPharma_PressRelease25042025.pdf

    PRESS RELEASE
    25 Apr 2025
    Share Share
    Right Brain Signs Suven Deal For RB-190 Targeting Parkinson’s Disease
    Right Brain Signs Suven Deal For RB-190 Targeting Parkinson’s Disease

    11 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/in-preparation-of-phase-ii-studies-right-brain-bio-signs-manufacturing-agreement-with-suven-pharmaceuticals-for-rb-190-to-target-the-root-cause-of-parkinsons-disease-302398363.html

    PR NEWSWIRE
    11 Mar 2025
    Share Share
    Suven Pharma Surges 14% on Heavy Volumes, Up 43% Since Jan
    Suven Pharma Surges 14% on Heavy Volumes, Up 43% Since Jan

    20 Feb 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/news/suven-pharma-soars-14-on-heavy-volumes-surges-43-from-january-low-125022000585_1.html

    BUSINESS STD
    20 Feb 2025
    Share Share
    Suven Pharma Shares Surge 12% On 78% PAT Growth In Q3
    Suven Pharma Shares Surge 12% On 78% PAT Growth In Q3

    13 Feb 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/news/suven-pharma-shares-zooms-12-on-strong-q3-nos-pat-up-78-rev-39-125021300749_1.html

    BUSINESS STD
    13 Feb 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Suven Pharmaceuticals and get a quotation

    Suven Pharmaceuticals is a supplier offers 8 products (APIs, Excipients or Intermediates).

    Find a price of Danofloxacin Mesylate bulk with DMF offered by Suven Pharmaceuticals

    Find a price of Edetate Calcium Disodium bulk with DMF offered by Suven Pharmaceuticals

    Find a price of Iron Sucrose bulk with DMF offered by Suven Pharmaceuticals

    Find a price of Isosulfan Blue bulk with DMF offered by Suven Pharmaceuticals

    Find a price of Probenecid bulk with DMF offered by Suven Pharmaceuticals

    Find a price of Doxofylline bulk offered by Suven Pharmaceuticals

    Find a price of Glycopyrronium Bromide bulk offered by Suven Pharmaceuticals

    Find a price of Tamsulosin bulk offered by Suven Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search